CTK Biotech

Preventable infections shouldn’t stand in the way of a healthy pregnancy. CTK’s OnSite® TORCH Panel Rapid Test helps identify treatable infections that threaten maternal and neonatal health supporting earlier intervention and better outcomes for both mother and baby.

Learn More: https://zurl.co/LDJFG

HIV risk factors frequently overlap with risk factors for other bloodborne diseases that can accelerate HIV disease progression and risk of transmission.

The CTK Biotech Portfolio provides a comprehensive range of reliable bloodborne rapid test panels that offer same-day detection of HIV and common coinfections, supporting better-informed, timely patient care decisions without the burden of multiple clinic visits.

Learn more at: https://zurl.co/eI9cS

Early detection of Syphilis infections plays a key role in preventing later-stage, systemic health complications. OnSite® Syphilis Ab Combo Rapid Test detects Syphilis antibodies in as early as 2 weeks post-infection, allowing clinicians to immediately intervene and begin treatment before physical signs of infection typically develop.

Learn more at: https://zurl.co/HdoXy

The OnSite® H. pylori Ag Rapid Test includes external controls in every kit, offering clinicians an all-in-one solution to confidently detect active H. pylori infections and assist with timely clinical interventions to reduce patient risk of chronic GI conditions and gastric cancer.

Learn more at: https://zurl.co/MeEBo

Influenza-like illnesses (ILIs) are difficult to differentiate without diagnostic testing. CTK’s comprehensive portfolio of infectious respiratory disease diagnostics eliminates the guesswork, empowering clinicians to make informed patient management decisions for patients with ILIs.

In regions where Hepatitis B is highly endemic, mother-to-child transmission at birth remains a leading cause of chronic infection.

The OnSite® HBsAg Combo Rapid Test offers 100% relative specificity in samples from pregnant women, providing a reliable tool for early detection and supporting better prenatal care for both mother and baby.

https://zurl.co/aITaY

Today is World Malaria Day. OnSite® Malaria Rapid Tests support simultaneous detection and differentiation of the 4 most prevalent Malaria parasites, guiding full-spectrum, point-of-care patient management.

Learn more: https://zurl.co/SEIYU

Chagas disease is responsible for significant morbidity and mortality in low-resource and rural communities in the Americas.

CTK’s OnSite® Chagas Ab Combo Rapid Test helps clinicians throughout the Americas overcome barriers to Chagas disease screening with accurate, fast, and cost-effective point of care test kits.

La enfermedad de Chagas cual es responsable de una alta morbilidad y mortalidad en comunidades rurales y de bajos recursos en las Américas.

La Prueba Rápida OnSite® Chagas Ab Combo de CTK ayuda a los clínicos en toda América a superar las barreras en la detección de la enfermedad de Chagas con pruebas en el punto de atención precisas, rápidas y rentables.

In high-throughput respiratory testing settings, assay controls are critical for ensuring test functionality, maintaining laboratory compliance, and protecting patient safety.

Each OnSite® COVID-19 + Influenza A/B Ag Rapid Test Kit includes assay-validated control swabs for COVID-19, Influenza A, and Influenza B, streamlining laboratory compliance.

Visit: https://zurl.co/Fj1Q7

Tuberculosis (TB) remains one of the world’s deadliest infectious diseases. This , join the mission to by educating yourself on the global health community’s strategy to reduce new cases of TB by 80% by 2030.

Visit: https://zurl.co/cF4LY